APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pet Veterinary Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pet Veterinary Drug Market Analysis and Forecast 2026-2032

22 December 2025198 pages

Choose your research edition.

Industry ResearchPet Veterinary Drug Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Pet Veterinary Drug Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Pet Veterinary Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pet Veterinary Drug Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Pet Veterinary Drug Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Pet Veterinary Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pet Veterinary Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pet Veterinary Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pet Veterinary Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pet Veterinary Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Pet Veterinary Drug include Bayer AG, Zoetis Animal Healthcare, Virbac Group, Vetoquinol, Orion Corporation, Merck Animal Health, Elanco Animal Health Inc., Dechra Pharmaceuticals Plc and Ceva, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pet Veterinary Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pet Veterinary Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Pet Veterinary Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pet Veterinary Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pet Veterinary Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pet Veterinary Drug sales, projected growth trends, production technology, application and end-user industry.

Pet Veterinary Drug Segment by Company

Bayer AG

Zoetis Animal Healthcare

Virbac Group

Vetoquinol

Orion Corporation

Merck Animal Health

Elanco Animal Health Inc.

Dechra Pharmaceuticals Plc

Ceva

Boehringer Ingelheim International GmbH

Pet Veterinary Drug Segment by Type

Analgesics

Sedatives

Parasiticides

Anti-Inflammatory

Anti-Infectives

Others

Pet Veterinary Drug Segment by Application

Veterinary Hospitals

Veterinary Clinics

Drug Stores

Pet Veterinary Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Veterinary Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Veterinary Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Veterinary Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pet Veterinary Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pet Veterinary Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pet Veterinary Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pet Veterinary Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Analgesics Major Manufacturers Table 3. Sedatives Major Manufacturers Table 4. Parasiticides Major Manufacturers Table 5. Anti-Inflammatory Major Manufacturers Table 6. Anti-Infectives Major Manufacturers Table 7. Others Major Manufacturers Table 8. Global Pet Veterinary Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Veterinary Hospitals Major Manufacturers Table 10. Veterinary Clinics Major Manufacturers Table 11. Drug Stores Major Manufacturers Table 12. Pet Veterinary Drug Industry Trends Table 13. Pet Veterinary Drug Industry Drivers Table 14. Pet Veterinary Drug Industry Opportunities and Challenges Table 15. Pet Veterinary Drug Industry Restraints Table 16. Global Pet Veterinary Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Pet Veterinary Drug Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Pet Veterinary Drug Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Pet Veterinary Drug Revenue Market Share by Region (2021-2026) Table 20. Global Pet Veterinary Drug Revenue Market Share by Region (2027-2032) Table 21. Global Pet Veterinary Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 22. Global Pet Veterinary Drug Sales by Region (2021-2026) & (k units) Table 23. Global Pet Veterinary Drug Sales by Region (2027-2032) & (k units) Table 24. Global Pet Veterinary Drug Sales Market Share by Region (2021-2026) Table 25. Global Pet Veterinary Drug Sales Market Share by Region (2027-2032) Table 26. Global Pet Veterinary Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Pet Veterinary Drug Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Pet Veterinary Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Pet Veterinary Drug Sales Market Share by Manufacturers (2021-2026) Table 30. Global Pet Veterinary Drug Sales Price (US$/unit) of Manufacturers (2021-2026) Table 31. Global Pet Veterinary Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Pet Veterinary Drug Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Pet Veterinary Drug Manufacturers, Product Type & Application Table 34. Global Pet Veterinary Drug Manufacturers' Establishment Date Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Pet Veterinary Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 37. Global Pet Veterinary Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Pet Veterinary Drug Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Pet Veterinary Drug Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Pet Veterinary Drug Revenue Market Share by Type (2021-2026) Table 41. Global Pet Veterinary Drug Revenue Market Share by Type (2027-2032) Table 42. Global Pet Veterinary Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 43. Global Pet Veterinary Drug Sales by Type (2021-2026) & (k units) Table 44. Global Pet Veterinary Drug Sales by Type (2027-2032) & (k units) Table 45. Global Pet Veterinary Drug Sales Market Share by Type (2021-2026) Table 46. Global Pet Veterinary Drug Sales Market Share by Type (2027-2032) Table 47. Global Pet Veterinary Drug Price by Type (2021-2026) & (US$/unit) Table 48. Global Pet Veterinary Drug Price by Type (2027-2032) & (US$/unit) Table 49. Global Pet Veterinary Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Pet Veterinary Drug Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Pet Veterinary Drug Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Pet Veterinary Drug Revenue Market Share by Application (2021-2026) Table 53. Global Pet Veterinary Drug Revenue Market Share by Application (2027-2032) Table 54. Global Pet Veterinary Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 55. Global Pet Veterinary Drug Sales by Application (2021-2026) & (k units) Table 56. Global Pet Veterinary Drug Sales by Application (2027-2032) & (k units) Table 57. Global Pet Veterinary Drug Sales Market Share by Application (2021-2026) Table 58. Global Pet Veterinary Drug Sales Market Share by Application (2027-2032) Table 59. Global Pet Veterinary Drug Price by Application (2021-2026) & (US$/unit) Table 60. Global Pet Veterinary Drug Price by Application (2027-2032) & (US$/unit) Table 61. Bayer AG Company Information Table 62. Bayer AG Business Overview Table 63. Bayer AG Pet Veterinary Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. Bayer AG Pet Veterinary Drug Product Portfolio Table 65. Bayer AG Recent Development Table 66. Zoetis Animal Healthcare Company Information Table 67. Zoetis Animal Healthcare Business Overview Table 68. Zoetis Animal Healthcare Pet Veterinary Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Zoetis Animal Healthcare Pet Veterinary Drug Product Portfolio Table 70. Zoetis Animal Healthcare Recent Development Table 71. Virbac Group Company Information Table 72. Virbac Group Business Overview Table 73. Virbac Group Pet Veterinary Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Virbac Group Pet Veterinary Drug Product Portfolio Table 75. Virbac Group Recent Development Table 76. Vetoquinol Company Information Table 77. Vetoquinol Business Overview Table 78. Vetoquinol Pet Veterinary Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Vetoquinol Pet Veterinary Drug Product Portfolio Table 80. Vetoquinol Recent Development Table 81. Orion Corporation Company Information Table 82. Orion Corporation Business Overview Table 83. Orion Corporation Pet Veterinary Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Orion Corporation Pet Veterinary Drug Product Portfolio Table 85. Orion Corporation Recent Development Table 86. Merck Animal Health Company Information Table 87. Merck Animal Health Business Overview Table 88. Merck Animal Health Pet Veterinary Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Merck Animal Health Pet Veterinary Drug Product Portfolio Table 90. Merck Animal Health Recent Development Table 91. Elanco Animal Health Inc. Company Information Table 92. Elanco Animal Health Inc. Business Overview Table 93. Elanco Animal Health Inc. Pet Veterinary Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Elanco Animal Health Inc. Pet Veterinary Drug Product Portfolio Table 95. Elanco Animal Health Inc. Recent Development Table 96. Dechra Pharmaceuticals Plc Company Information Table 97. Dechra Pharmaceuticals Plc Business Overview Table 98. Dechra Pharmaceuticals Plc Pet Veterinary Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Dechra Pharmaceuticals Plc Pet Veterinary Drug Product Portfolio Table 100. Dechra Pharmaceuticals Plc Recent Development Table 101. Ceva Company Information Table 102. Ceva Business Overview Table 103. Ceva Pet Veterinary Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Ceva Pet Veterinary Drug Product Portfolio Table 105. Ceva Recent Development Table 106. Boehringer Ingelheim International GmbH Company Information Table 107. Boehringer Ingelheim International GmbH Business Overview Table 108. Boehringer Ingelheim International GmbH Pet Veterinary Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Boehringer Ingelheim International GmbH Pet Veterinary Drug Product Portfolio Table 110. Boehringer Ingelheim International GmbH Recent Development Table 111. North America Pet Veterinary Drug Revenue by Type (2021-2026) & (US$ Million) Table 112. North America Pet Veterinary Drug Revenue by Type (2027-2032) & (US$ Million) Table 113. North America Pet Veterinary Drug Sales by Type (2021-2026) & (k units) Table 114. North America Pet Veterinary Drug Sales by Type (2027-2032) & (k units) Table 115. North America Pet Veterinary Drug Sales Price by Type (2021-2026) & (US$/unit) Table 116. North America Pet Veterinary Drug Sales Price by Type (2027-2032) & (US$/unit) Table 117. North America Pet Veterinary Drug Revenue by Application (2021-2026) & (US$ Million) Table 118. North America Pet Veterinary Drug Revenue by Application (2027-2032) & (US$ Million) Table 119. North America Pet Veterinary Drug Sales by Application (2021-2026) & (k units) Table 120. North America Pet Veterinary Drug Sales by Application (2027-2032) & (k units) Table 121. North America Pet Veterinary Drug Sales Price by Application (2021-2026) & (US$/unit) Table 122. North America Pet Veterinary Drug Sales Price by Application (2027-2032) & (US$/unit) Table 123. North America Pet Veterinary Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. North America Pet Veterinary Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 125. North America Pet Veterinary Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 126. North America Pet Veterinary Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 127. North America Pet Veterinary Drug Sales by Country (2021-2026) & (k units) Table 128. North America Pet Veterinary Drug Sales by Country (2027-2032) & (k units) Table 129. North America Pet Veterinary Drug Sales Price by Country (2021-2026) & (US$/unit) Table 130. North America Pet Veterinary Drug Sales Price by Country (2027-2032) & (US$/unit) Table 131. United States Pet Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 132. Canada Pet Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 133. Mexico Pet Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 134. Europe Pet Veterinary Drug Revenue by Type (2021-2026) & (US$ Million) Table 135. Europe Pet Veterinary Drug Revenue by Type (2027-2032) & (US$ Million) Table 136. Europe Pet Veterinary Drug Sales by Type (2021-2026) & (k units) Table 137. Europe Pet Veterinary Drug Sales by Type (2027-2032) & (k units) Table 138. Europe Pet Veterinary Drug Sales Price by Type (2021-2026) & (US$/unit) Table 139. Europe Pet Veterinary Drug Sales Price by Type (2027-2032) & (US$/unit) Table 140. Europe Pet Veterinary Drug Revenue by Application (2021-2026) & (US$ Million) Table 141. Europe Pet Veterinary Drug Revenue by Application (2027-2032) & (US$ Million) Table 142. Europe Pet Veterinary Drug Sales by Application (2021-2026) & (k units) Table 143. Europe Pet Veterinary Drug Sales by Application (2027-2032) & (k units) Table 144. Europe Pet Veterinary Drug Sales Price by Application (2021-2026) & (US$/unit) Table 145. Europe Pet Veterinary Drug Sales Price by Application (2027-2032) & (US$/unit) Table 146. Europe Pet Veterinary Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Europe Pet Veterinary Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 148. Europe Pet Veterinary Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 149. Europe Pet Veterinary Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 150. Europe Pet Veterinary Drug Sales by Country (2021-2026) & (k units) Table 151. Europe Pet Veterinary Drug Sales by Country (2027-2032) & (k units) Table 152. Europe Pet Veterinary Drug Sales Price by Country (2021-2026) & (US$/unit) Table 153. Europe Pet Veterinary Drug Sales Price by Country (2027-2032) & (US$/unit) Table 154. Germany Pet Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 155. France Pet Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 156. U.K. Pet Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 157. Italy Pet Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 158. Russia Pet Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 159. Spain Pet Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 160. Netherlands Pet Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 161. Switzerland Pet Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 162. Sweden Pet Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 163. Poland Pet Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 164. China Pet Veterinary Drug Revenue by Type (2021-2026) & (US$ Million) Table 165. China Pet Veterinary Drug Revenue by Type (2027-2032) & (US$ Million) Table 166. China Pet Veterinary Drug Sales by Type (2021-2026) & (k units) Table 167. China Pet Veterinary Drug Sales by Type (2027-2032) & (k units) Table 168. China Pet Veterinary Drug Sales Price by Type (2021-2026) & (US$/unit) Table 169. China Pet Veterinary Drug Sales Price by Type (2027-2032) & (US$/unit) Table 170. China Pet Veterinary Drug Revenue by Application (2021-2026) & (US$ Million) Table 171. China Pet Veterinary Drug Revenue by Application (2027-2032) & (US$ Million) Table 172. China Pet Veterinary Drug Sales by Application (2021-2026) & (k units) Table 173. China Pet Veterinary Drug Sales by Application (2027-2032) & (k units) Table 174. China Pet Veterinary Drug Sales Price by Application (2021-2026) & (US$/unit) Table 175. China Pet Veterinary Drug Sales Price by Application (2027-2032) & (US$/unit) Table 176. Asia Pet Veterinary Drug Revenue by Type (2021-2026) & (US$ Million) Table 177. Asia Pet Veterinary Drug Revenue by Type (2027-2032) & (US$ Million) Table 178. Asia Pet Veterinary Drug Sales by Type (2021-2026) & (k units) Table 179. Asia Pet Veterinary Drug Sales by Type (2027-2032) & (k units) Table 180. Asia Pet Veterinary Drug Sales Price by Type (2021-2026) & (US$/unit) Table 181. Asia Pet Veterinary Drug Sales Price by Type (2027-2032) & (US$/unit) Table 182. Asia Pet Veterinary Drug Revenue by Application (2021-2026) & (US$ Million) Table 183. Asia Pet Veterinary Drug Revenue by Application (2027-2032) & (US$ Million) Table 184. Asia Pet Veterinary Drug Sales by Application (2021-2026) & (k units) Table 185. Asia Pet Veterinary Drug Sales by Application (2027-2032) & (k units) Table 186. Asia Pet Veterinary Drug Sales Price by Application (2021-2026) & (US$/unit) Table 187. Asia Pet Veterinary Drug Sales Price by Application (2027-2032) & (US$/unit) Table 188. Asia Pet Veterinary Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 189. Asia Pet Veterinary Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 190. Asia Pet Veterinary Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 191. Asia Pet Veterinary Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 192. Asia Pet Veterinary Drug Sales by Country (2021-2026) & (k units) Table 193. Asia Pet Veterinary Drug Sales by Country (2027-2032) & (k units) Table 194. Asia Pet Veterinary Drug Sales Price by Country (2021-2026) & (US$/unit) Table 195. Asia Pet Veterinary Drug Sales Price by Country (2027-2032) & (US$/unit) Table 196. Japan Pet Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 197. South Korea Pet Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 198. India Pet Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 199. Australia Pet Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 200. Taiwan Pet Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 201. Southeast Asia Pet Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 202. SAMEA Pet Veterinary Drug Revenue by Type (2021-2026) & (US$ Million) Table 203. SAMEA Pet Veterinary Drug Revenue by Type (2027-2032) & (US$ Million) Table 204. SAMEA Pet Veterinary Drug Sales by Type (2021-2026) & (k units) Table 205. SAMEA Pet Veterinary Drug Sales by Type (2027-2032) & (k units) Table 206. SAMEA Pet Veterinary Drug Sales Price by Type (2021-2026) & (US$/unit) Table 207. SAMEA Pet Veterinary Drug Sales Price by Type (2027-2032) & (US$/unit) Table 208. SAMEA Pet Veterinary Drug Revenue by Application (2021-2026) & (US$ Million) Table 209. SAMEA Pet Veterinary Drug Revenue by Application (2027-2032) & (US$ Million) Table 210. SAMEA Pet Veterinary Drug Sales by Application (2021-2026) & (k units) Table 211. SAMEA Pet Veterinary Drug Sales by Application (2027-2032) & (k units) Table 212. SAMEA Pet Veterinary Drug Sales Price by Application (2021-2026) & (US$/unit) Table 213. SAMEA Pet Veterinary Drug Sales Price by Application (2027-2032) & (US$/unit) Table 214. SAMEA Pet Veterinary Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 215. SAMEA Pet Veterinary Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 216. SAMEA Pet Veterinary Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 217. SAMEA Pet Veterinary Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 218. SAMEA Pet Veterinary Drug Sales by Country (2021-2026) & (k units) Table 219. SAMEA Pet Veterinary Drug Sales by Country (2027-2032) & (k units) Table 220. SAMEA Pet Veterinary Drug Sales Price by Country (2021-2026) & (US$/unit) Table 221. SAMEA Pet Veterinary Drug Sales Price by Country (2027-2032) & (US$/unit) Table 222. Brazil Pet Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 223. Argentina Pet Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 224. Chile Pet Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 225. Colombia Pet Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 226. Peru Pet Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 227. Saudi Arabia Pet Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 228. Israel Pet Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 229. UAE Pet Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 230. Turkey Pet Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 231. Iran Pet Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 232. Egypt Pet Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 233. Key Raw Materials Table 234. Raw Materials Key Suppliers Table 235. Pet Veterinary Drug Distributors List Table 236. Pet Veterinary Drug Customers List Table 237. Research Programs/Design for This Report Table 238. Authors List of This Report Table 239. Secondary Sources Table 240. Primary Sources List of Figures Figure 1. Pet Veterinary Drug Image Figure 2. Global Pet Veterinary Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pet Veterinary Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Analgesics Image Figure 5. Sedatives Image Figure 6. Parasiticides Image Figure 7. Anti-Inflammatory Image Figure 8. Anti-Infectives Image Figure 9. Others Image Figure 10. Global Pet Veterinary Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Pet Veterinary Drug Market Size Share 2021 VS 2025 VS 2032 Figure 12. Veterinary Hospitals Image Figure 13. Veterinary Clinics Image Figure 14. Drug Stores Image Figure 15. Global Pet Veterinary Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Pet Veterinary Drug Revenue (2021-2032) & (US$ Million) Figure 17. Global Pet Veterinary Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Pet Veterinary Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Pet Veterinary Drug Revenue Market Share by Region (2021-2032) Figure 20. Global Pet Veterinary Drug Sales (2021-2032) & (k units) Figure 21. Global Pet Veterinary Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 22. Global Pet Veterinary Drug Sales Market Share by Region (2021-2032) Figure 23. US & Canada & Mexico Pet Veterinary Drug Sales YoY (2021-2032) & (k units) Figure 24. Europe Pet Veterinary Drug Sales YoY (2021-2032) & (k units) Figure 25. China Pet Veterinary Drug Sales YoY (2021-2032) & (k units) Figure 26. Asia (Excluding China) Pet Veterinary Drug Sales YoY (2021-2032) & (k units) Figure 27. South America, Middle East and Africa Pet Veterinary Drug Sales YoY (2021-2032) & (k units) Figure 28. Global Pet Veterinary Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Pet Veterinary Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Pet Veterinary Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Pet Veterinary Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Pet Veterinary Drug Revenue Market Share by Type (2021-2032) Figure 34. Global Pet Veterinary Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 35. Global Pet Veterinary Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Pet Veterinary Drug Sales Market Share by Type (2021-2032) Figure 37. Global Pet Veterinary Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 38. Global Pet Veterinary Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Pet Veterinary Drug Revenue Market Share by Application (2021-2032) Figure 40. Global Pet Veterinary Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 41. Global Pet Veterinary Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Pet Veterinary Drug Sales Market Share by Application (2021-2032) Figure 43. North America Pet Veterinary Drug Revenue Share by Type (2021-2032) Figure 44. North America Pet Veterinary Drug Sales Share by Type (2021-2032) Figure 45. North America Pet Veterinary Drug Revenue Share by Application (2021-2032) Figure 46. North America Pet Veterinary Drug Sales Share by Application (2021-2032) Figure 47. North America Pet Veterinary Drug Revenue Share by Country (2021-2032) Figure 48. North America Pet Veterinary Drug Sales Share by Country (2021-2032) Figure 49. Europe Pet Veterinary Drug Revenue Share by Type (2021-2032) Figure 50. Europe Pet Veterinary Drug Sales Share by Type (2021-2032) Figure 51. Europe Pet Veterinary Drug Revenue Share by Application (2021-2032) Figure 52. Europe Pet Veterinary Drug Sales Share by Application (2021-2032) Figure 53. Europe Pet Veterinary Drug Revenue Share by Country (2021-2032) Figure 54. Europe Pet Veterinary Drug Sales Share by Country (2021-2032) Figure 55. China Pet Veterinary Drug Revenue Share by Type (2021-2032) Figure 56. China Pet Veterinary Drug Sales Share by Type (2021-2032) Figure 57. China Pet Veterinary Drug Revenue Share by Application (2021-2032) Figure 58. China Pet Veterinary Drug Sales Share by Application (2021-2032) Figure 59. Asia Pet Veterinary Drug Revenue Share by Type (2021-2032) Figure 60. Asia Pet Veterinary Drug Sales Share by Type (2021-2032) Figure 61. Asia Pet Veterinary Drug Revenue Share by Application (2021-2032) Figure 62. Asia Pet Veterinary Drug Sales Share by Application (2021-2032) Figure 63. Asia Pet Veterinary Drug Revenue Share by Country (2021-2032) Figure 64. Asia Pet Veterinary Drug Sales Share by Country (2021-2032) Figure 65. SAMEA Pet Veterinary Drug Revenue Share by Type (2021-2032) Figure 66. SAMEA Pet Veterinary Drug Sales Share by Type (2021-2032) Figure 67. SAMEA Pet Veterinary Drug Revenue Share by Application (2021-2032) Figure 68. SAMEA Pet Veterinary Drug Sales Share by Application (2021-2032) Figure 69. SAMEA Pet Veterinary Drug Revenue Share by Country (2021-2032) Figure 70. SAMEA Pet Veterinary Drug Sales Share by Country (2021-2032) Figure 71. Pet Veterinary Drug Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Pet Veterinary Drug Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Analgesics
  • Sedatives
  • Parasiticides
  • Anti-Inflammatory
  • Anti-Infectives
  • Others
Applications
  • Veterinary Hospitals
  • Veterinary Clinics
  • Drug Stores
Companies covered
  • Bayer AG
  • Zoetis Animal Healthcare
  • Virbac Group
  • Vetoquinol
  • Orion Corporation
  • Merck Animal Health
  • Elanco Animal Health Inc.
  • Dechra Pharmaceuticals Plc
  • Ceva
  • Boehringer Ingelheim International GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pet Veterinary Drug Market by Type
  3. 1.2.1 Global Pet Veterinary Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Analgesics
  5. 1.2.3 Sedatives
  6. 1.2.4 Parasiticides
  7. 1.2.5 Anti-Inflammatory
  8. 1.2.6 Anti-Infectives
  9. 1.2.7 Others
  10. 1.3 Pet Veterinary Drug Market by Application
  11. 1.3.1 Global Pet Veterinary Drug Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Veterinary Hospitals
  13. 1.3.3 Veterinary Clinics
  14. 1.3.4 Drug Stores
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Pet Veterinary Drug Market Dynamics
  1. 2.1 Pet Veterinary Drug Industry Trends
  2. 2.2 Pet Veterinary Drug Industry Drivers
  3. 2.3 Pet Veterinary Drug Industry Opportunities and Challenges
  4. 2.4 Pet Veterinary Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pet Veterinary Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pet Veterinary Drug Revenue by Region
  3. 3.2.1 Global Pet Veterinary Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pet Veterinary Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Pet Veterinary Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Pet Veterinary Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pet Veterinary Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pet Veterinary Drug Sales by Region
  9. 3.4.1 Global Pet Veterinary Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pet Veterinary Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Pet Veterinary Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Pet Veterinary Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pet Veterinary Drug Revenue by Manufacturers
  2. 4.1.1 Global Pet Veterinary Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pet Veterinary Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pet Veterinary Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pet Veterinary Drug Sales by Manufacturers
  6. 4.2.1 Global Pet Veterinary Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pet Veterinary Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pet Veterinary Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pet Veterinary Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pet Veterinary Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pet Veterinary Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pet Veterinary Drug Manufacturers, Product Type & Application
  13. 4.7 Global Pet Veterinary Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pet Veterinary Drug Market CR5 and HHI
  16. 4.8.2 2025 Pet Veterinary Drug Tier 1, Tier 2, and Tier 3
5 Pet Veterinary Drug Market by Type
  1. 5.1 Global Pet Veterinary Drug Revenue by Type
  2. 5.1.1 Global Pet Veterinary Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pet Veterinary Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pet Veterinary Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pet Veterinary Drug Sales by Type
  6. 5.2.1 Global Pet Veterinary Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pet Veterinary Drug Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Pet Veterinary Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pet Veterinary Drug Price by Type
6 Pet Veterinary Drug Market by Application
  1. 6.1 Global Pet Veterinary Drug Revenue by Application
  2. 6.1.1 Global Pet Veterinary Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pet Veterinary Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pet Veterinary Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pet Veterinary Drug Sales by Application
  6. 6.2.1 Global Pet Veterinary Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pet Veterinary Drug Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Pet Veterinary Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pet Veterinary Drug Price by Application
7 Company Profiles
  1. 7.1 Bayer AG
  2. 7.1.1 Bayer AG Company Information
  3. 7.1.2 Bayer AG Business Overview
  4. 7.1.3 Bayer AG Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Bayer AG Pet Veterinary Drug Product Portfolio
  6. 7.1.5 Bayer AG Recent Developments
  7. 7.2 Zoetis Animal Healthcare
  8. 7.2.1 Zoetis Animal Healthcare Company Information
  9. 7.2.2 Zoetis Animal Healthcare Business Overview
  10. 7.2.3 Zoetis Animal Healthcare Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Zoetis Animal Healthcare Pet Veterinary Drug Product Portfolio
  12. 7.2.5 Zoetis Animal Healthcare Recent Developments
  13. 7.3 Virbac Group
  14. 7.3.1 Virbac Group Company Information
  15. 7.3.2 Virbac Group Business Overview
  16. 7.3.3 Virbac Group Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Virbac Group Pet Veterinary Drug Product Portfolio
  18. 7.3.5 Virbac Group Recent Developments
  19. 7.4 Vetoquinol
  20. 7.4.1 Vetoquinol Company Information
  21. 7.4.2 Vetoquinol Business Overview
  22. 7.4.3 Vetoquinol Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Vetoquinol Pet Veterinary Drug Product Portfolio
  24. 7.4.5 Vetoquinol Recent Developments
  25. 7.5 Orion Corporation
  26. 7.5.1 Orion Corporation Company Information
  27. 7.5.2 Orion Corporation Business Overview
  28. 7.5.3 Orion Corporation Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Orion Corporation Pet Veterinary Drug Product Portfolio
  30. 7.5.5 Orion Corporation Recent Developments
  31. 7.6 Merck Animal Health
  32. 7.6.1 Merck Animal Health Company Information
  33. 7.6.2 Merck Animal Health Business Overview
  34. 7.6.3 Merck Animal Health Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Merck Animal Health Pet Veterinary Drug Product Portfolio
  36. 7.6.5 Merck Animal Health Recent Developments
  37. 7.7 Elanco Animal Health Inc.
  38. 7.7.1 Elanco Animal Health Inc. Company Information
  39. 7.7.2 Elanco Animal Health Inc. Business Overview
  40. 7.7.3 Elanco Animal Health Inc. Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Elanco Animal Health Inc. Pet Veterinary Drug Product Portfolio
  42. 7.7.5 Elanco Animal Health Inc. Recent Developments
  43. 7.8 Dechra Pharmaceuticals Plc
  44. 7.8.1 Dechra Pharmaceuticals Plc Company Information
  45. 7.8.2 Dechra Pharmaceuticals Plc Business Overview
  46. 7.8.3 Dechra Pharmaceuticals Plc Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Dechra Pharmaceuticals Plc Pet Veterinary Drug Product Portfolio
  48. 7.8.5 Dechra Pharmaceuticals Plc Recent Developments
  49. 7.9 Ceva
  50. 7.9.1 Ceva Company Information
  51. 7.9.2 Ceva Business Overview
  52. 7.9.3 Ceva Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Ceva Pet Veterinary Drug Product Portfolio
  54. 7.9.5 Ceva Recent Developments
  55. 7.10 Boehringer Ingelheim International GmbH
  56. 7.10.1 Boehringer Ingelheim International GmbH Company Information
  57. 7.10.2 Boehringer Ingelheim International GmbH Business Overview
  58. 7.10.3 Boehringer Ingelheim International GmbH Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Boehringer Ingelheim International GmbH Pet Veterinary Drug Product Portfolio
  60. 7.10.5 Boehringer Ingelheim International GmbH Recent Developments
8 North America
  1. 8.1 North America Pet Veterinary Drug Market Size by Type
  2. 8.1.1 North America Pet Veterinary Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Pet Veterinary Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Pet Veterinary Drug Price by Type (2021-2032)
  5. 8.2 North America Pet Veterinary Drug Market Size by Application
  6. 8.2.1 North America Pet Veterinary Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Pet Veterinary Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Pet Veterinary Drug Price by Application (2021-2032)
  9. 8.3 North America Pet Veterinary Drug Market Size by Country
  10. 8.3.1 North America Pet Veterinary Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pet Veterinary Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pet Veterinary Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Pet Veterinary Drug Market Size by Type
  2. 9.1.1 Europe Pet Veterinary Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pet Veterinary Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Pet Veterinary Drug Price by Type (2021-2032)
  5. 9.2 Europe Pet Veterinary Drug Market Size by Application
  6. 9.2.1 Europe Pet Veterinary Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pet Veterinary Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Pet Veterinary Drug Price by Application (2021-2032)
  9. 9.3 Europe Pet Veterinary Drug Market Size by Country
  10. 9.3.1 Europe Pet Veterinary Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pet Veterinary Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pet Veterinary Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Pet Veterinary Drug Market Size by Type
  2. 10.1.1 China Pet Veterinary Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Pet Veterinary Drug Sales by Type (2021-2032)
  4. 10.1.3 China Pet Veterinary Drug Price by Type (2021-2032)
  5. 10.2 China Pet Veterinary Drug Market Size by Application
  6. 10.2.1 China Pet Veterinary Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Pet Veterinary Drug Sales by Application (2021-2032)
  8. 10.2.3 China Pet Veterinary Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pet Veterinary Drug Market Size by Type
  2. 11.1.1 Asia Pet Veterinary Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pet Veterinary Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Pet Veterinary Drug Price by Type (2021-2032)
  5. 11.2 Asia Pet Veterinary Drug Market Size by Application
  6. 11.2.1 Asia Pet Veterinary Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pet Veterinary Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Pet Veterinary Drug Price by Application (2021-2032)
  9. 11.3 Asia Pet Veterinary Drug Market Size by Country
  10. 11.3.1 Asia Pet Veterinary Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pet Veterinary Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pet Veterinary Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pet Veterinary Drug Market Size by Type
  2. 12.1.1 SAMEA Pet Veterinary Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pet Veterinary Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pet Veterinary Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Pet Veterinary Drug Market Size by Application
  6. 12.2.1 SAMEA Pet Veterinary Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pet Veterinary Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pet Veterinary Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Pet Veterinary Drug Market Size by Country
  10. 12.3.1 SAMEA Pet Veterinary Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pet Veterinary Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pet Veterinary Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pet Veterinary Drug Value Chain Analysis
  2. 13.1.1 Pet Veterinary Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pet Veterinary Drug Production Mode & Process
  6. 13.2 Pet Veterinary Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pet Veterinary Drug Distributors
  9. 13.2.3 Pet Veterinary Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst